Reviewed by the Compound Universe Research Team | Last updated July 2026 The ipamorelin vs sermorelin question comes up constantly because both peptides raise growth hormone, yet they do it through completely different doors. Ipamorelin works on the ghrelin receptor; sermorelin copies a hormone the body already uses to signal the pituitary. That single difference … Read more
Reviewed by the Compound Universe Research Team | Last updated July 2026 The retatrutide vs tirzepatide question comes down to one structural difference: how many hormone receptors each molecule activates. Tirzepatide is a dual agonist that hits two receptors and is already FDA-approved. Retatrutide is a triple agonist that adds a third, and as of … Read more
Reviewed by the Compound Universe Research Team | Last updated July 2026 Retatrutide vs tirzepatide vs semaglutide comes down to three stages of one drug class: approved and established, approved and stronger head-to-head, and still in trials. All three act on the incretin system controlling appetite and blood sugar, but each hits a different number … Read more